RALA and familial pancreatic carcinoma: Falsetti et al. expressed farnesylated C-terminal domains of RALA or RALB in Cos7 cells and MiaPaCa2 pancreatic cancer cells to shield them from GGTase-I inhibitors (GGTIs) [84].